Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC319221 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9918 | High Similarity | NPC324009 |
0.968 | High Similarity | NPC61198 |
0.96 | High Similarity | NPC262926 |
0.9167 | High Similarity | NPC211820 |
0.9167 | High Similarity | NPC251233 |
0.916 | High Similarity | NPC186619 |
0.9098 | High Similarity | NPC89147 |
0.9098 | High Similarity | NPC177169 |
0.9098 | High Similarity | NPC274384 |
0.903 | High Similarity | NPC232408 |
0.903 | High Similarity | NPC64705 |
0.9023 | High Similarity | NPC318590 |
0.8955 | High Similarity | NPC317746 |
0.8923 | High Similarity | NPC320818 |
0.8788 | High Similarity | NPC30326 |
0.848 | Intermediate Similarity | NPC327579 |
0.8394 | Intermediate Similarity | NPC315642 |
0.8394 | Intermediate Similarity | NPC74306 |
0.8176 | Intermediate Similarity | NPC14590 |
0.8085 | Intermediate Similarity | NPC164665 |
0.8014 | Intermediate Similarity | NPC156461 |
0.8014 | Intermediate Similarity | NPC107374 |
0.8014 | Intermediate Similarity | NPC21448 |
0.7958 | Intermediate Similarity | NPC189068 |
0.7902 | Intermediate Similarity | NPC309832 |
0.7902 | Intermediate Similarity | NPC269827 |
0.7902 | Intermediate Similarity | NPC219313 |
0.7872 | Intermediate Similarity | NPC229974 |
0.7785 | Intermediate Similarity | NPC311197 |
0.7785 | Intermediate Similarity | NPC54320 |
0.7785 | Intermediate Similarity | NPC313754 |
0.7755 | Intermediate Similarity | NPC321052 |
0.773 | Intermediate Similarity | NPC161659 |
0.773 | Intermediate Similarity | NPC209525 |
0.7718 | Intermediate Similarity | NPC52238 |
0.7687 | Intermediate Similarity | NPC211025 |
0.7687 | Intermediate Similarity | NPC185991 |
0.7687 | Intermediate Similarity | NPC85689 |
0.7635 | Intermediate Similarity | NPC321814 |
0.7635 | Intermediate Similarity | NPC472816 |
0.7622 | Intermediate Similarity | NPC314152 |
0.7606 | Intermediate Similarity | NPC317821 |
0.7584 | Intermediate Similarity | NPC130586 |
0.7584 | Intermediate Similarity | NPC302778 |
0.7584 | Intermediate Similarity | NPC164952 |
0.7584 | Intermediate Similarity | NPC212551 |
0.755 | Intermediate Similarity | NPC239737 |
0.7533 | Intermediate Similarity | NPC174802 |
0.75 | Intermediate Similarity | NPC150853 |
0.75 | Intermediate Similarity | NPC326694 |
0.7483 | Intermediate Similarity | NPC121222 |
0.7483 | Intermediate Similarity | NPC224076 |
0.7436 | Intermediate Similarity | NPC261595 |
0.7434 | Intermediate Similarity | NPC316618 |
0.7434 | Intermediate Similarity | NPC226245 |
0.74 | Intermediate Similarity | NPC207633 |
0.7389 | Intermediate Similarity | NPC321458 |
0.7389 | Intermediate Similarity | NPC324033 |
0.7333 | Intermediate Similarity | NPC161224 |
0.7292 | Intermediate Similarity | NPC129756 |
0.72 | Intermediate Similarity | NPC136349 |
0.7197 | Intermediate Similarity | NPC323091 |
0.7059 | Intermediate Similarity | NPC328479 |
0.6992 | Remote Similarity | NPC313547 |
0.6986 | Remote Similarity | NPC33996 |
0.6953 | Remote Similarity | NPC10466 |
0.6943 | Remote Similarity | NPC195140 |
0.6909 | Remote Similarity | NPC189261 |
0.6848 | Remote Similarity | NPC326529 |
0.6825 | Remote Similarity | NPC320256 |
0.6822 | Remote Similarity | NPC59314 |
0.6807 | Remote Similarity | NPC324198 |
0.6807 | Remote Similarity | NPC319100 |
0.6772 | Remote Similarity | NPC93365 |
0.6728 | Remote Similarity | NPC324484 |
0.6718 | Remote Similarity | NPC119133 |
0.6707 | Remote Similarity | NPC290959 |
0.6707 | Remote Similarity | NPC326082 |
0.6687 | Remote Similarity | NPC325906 |
0.6667 | Remote Similarity | NPC41958 |
0.6647 | Remote Similarity | NPC313897 |
0.6589 | Remote Similarity | NPC293163 |
0.6457 | Remote Similarity | NPC313514 |
0.6449 | Remote Similarity | NPC63433 |
0.6369 | Remote Similarity | NPC222174 |
0.6341 | Remote Similarity | NPC321393 |
0.6286 | Remote Similarity | NPC24589 |
0.6271 | Remote Similarity | NPC282458 |
0.6271 | Remote Similarity | NPC78941 |
0.619 | Remote Similarity | NPC33382 |
0.6154 | Remote Similarity | NPC125659 |
0.6154 | Remote Similarity | NPC168702 |
0.6127 | Remote Similarity | NPC240084 |
0.6119 | Remote Similarity | NPC476561 |
0.5979 | Remote Similarity | NPC157821 |
0.5973 | Remote Similarity | NPC180462 |
0.5957 | Remote Similarity | NPC276373 |
0.5926 | Remote Similarity | NPC5802 |
0.5879 | Remote Similarity | NPC250178 |
0.5875 | Remote Similarity | NPC174020 |
0.585 | Remote Similarity | NPC139776 |
0.5797 | Remote Similarity | NPC476562 |
0.5779 | Remote Similarity | NPC57279 |
0.5772 | Remote Similarity | NPC109322 |
0.5752 | Remote Similarity | NPC287876 |
0.5749 | Remote Similarity | NPC60537 |
0.5743 | Remote Similarity | NPC470142 |
0.5736 | Remote Similarity | NPC328806 |
0.5733 | Remote Similarity | NPC248007 |
0.5732 | Remote Similarity | NPC470141 |
0.5729 | Remote Similarity | NPC103388 |
0.5686 | Remote Similarity | NPC14330 |
0.5683 | Remote Similarity | NPC476564 |
0.5674 | Remote Similarity | NPC75131 |
0.566 | Remote Similarity | NPC210947 |
0.5659 | Remote Similarity | NPC190334 |
0.5659 | Remote Similarity | NPC62927 |
0.5658 | Remote Similarity | NPC144223 |
0.5649 | Remote Similarity | NPC246193 |
0.5625 | Remote Similarity | NPC185903 |
0.5613 | Remote Similarity | NPC470138 |
0.5604 | Remote Similarity | NPC107160 |
0.56 | Remote Similarity | NPC5707 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC319221 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.968 | High Similarity | NPD252 | Clinical (unspecified phase) |
0.9291 | High Similarity | NPD194 | Clinical (unspecified phase) |
0.928 | High Similarity | NPD9632 | Phase 3 |
0.9231 | High Similarity | NPD549 | Approved |
0.8571 | High Similarity | NPD3086 | Phase 3 |
0.85 | High Similarity | NPD3085 | Phase 1 |
0.848 | Intermediate Similarity | NPD9607 | Approved |
0.84 | Intermediate Similarity | NPD9606 | Approved |
0.8394 | Intermediate Similarity | NPD582 | Approved |
0.8345 | Intermediate Similarity | NPD4074 | Clinical (unspecified phase) |
0.8209 | Intermediate Similarity | NPD209 | Clinical (unspecified phase) |
0.816 | Intermediate Similarity | NPD9374 | Approved |
0.8134 | Intermediate Similarity | NPD545 | Clinical (unspecified phase) |
0.8047 | Intermediate Similarity | NPD307 | Approved |
0.8014 | Intermediate Similarity | NPD250 | Approved |
0.8014 | Intermediate Similarity | NPD249 | Approved |
0.8 | Intermediate Similarity | NPD547 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD536 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD9373 | Approved |
0.7902 | Intermediate Similarity | NPD195 | Approved |
0.7902 | Intermediate Similarity | NPD186 | Discovery |
0.7785 | Intermediate Similarity | NPD217 | Approved |
0.7785 | Intermediate Similarity | NPD216 | Approved |
0.7785 | Intermediate Similarity | NPD220 | Clinical (unspecified phase) |
0.7785 | Intermediate Similarity | NPD219 | Phase 3 |
0.7785 | Intermediate Similarity | NPD218 | Approved |
0.7703 | Intermediate Similarity | NPD1369 | Phase 2 |
0.7703 | Intermediate Similarity | NPD1750 | Clinical (unspecified phase) |
0.7687 | Intermediate Similarity | NPD283 | Approved |
0.7676 | Intermediate Similarity | NPD1430 | Approved |
0.7676 | Intermediate Similarity | NPD1431 | Approved |
0.7667 | Intermediate Similarity | NPD2624 | Phase 2 |
0.7622 | Intermediate Similarity | NPD185 | Approved |
0.7603 | Intermediate Similarity | NPD775 | Approved |
0.7584 | Intermediate Similarity | NPD338 | Approved |
0.7584 | Intermediate Similarity | NPD242 | Approved |
0.7584 | Intermediate Similarity | NPD3107 | Discontinued |
0.7584 | Intermediate Similarity | NPD214 | Approved |
0.7584 | Intermediate Similarity | NPD213 | Clinical (unspecified phase) |
0.7576 | Intermediate Similarity | NPD9409 | Discontinued |
0.755 | Intermediate Similarity | NPD2646 | Discontinued |
0.755 | Intermediate Similarity | NPD1732 | Phase 3 |
0.7533 | Intermediate Similarity | NPD339 | Approved |
0.7517 | Intermediate Similarity | NPD166 | Approved |
0.75 | Intermediate Similarity | NPD9375 | Discontinued |
0.7483 | Intermediate Similarity | NPD169 | Phase 2 |
0.7483 | Intermediate Similarity | NPD193 | Suspended |
0.7465 | Intermediate Similarity | NPD1808 | Phase 1 |
0.745 | Intermediate Similarity | NPD353 | Discontinued |
0.7436 | Intermediate Similarity | NPD247 | Clinical (unspecified phase) |
0.7324 | Intermediate Similarity | NPD1120 | Approved |
0.7324 | Intermediate Similarity | NPD1121 | Approved |
0.7293 | Intermediate Similarity | NPD237 | Clinical (unspecified phase) |
0.7285 | Intermediate Similarity | NPD9605 | Phase 3 |
0.7246 | Intermediate Similarity | NPD515 | Phase 1 |
0.72 | Intermediate Similarity | NPD548 | Clinical (unspecified phase) |
0.7091 | Intermediate Similarity | NPD4716 | Approved |
0.7068 | Intermediate Similarity | NPD9584 | Phase 2 |
0.7063 | Intermediate Similarity | NPD2647 | Phase 3 |
0.7048 | Intermediate Similarity | NPD4744 | Clinical (unspecified phase) |
0.7037 | Intermediate Similarity | NPD9360 | Approved |
0.6993 | Remote Similarity | NPD7842 | Phase 2 |
0.6951 | Remote Similarity | NPD5666 | Phase 2 |
0.6899 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.6864 | Remote Similarity | NPD1692 | Approved |
0.6822 | Remote Similarity | NPD8837 | Clinical (unspecified phase) |
0.6807 | Remote Similarity | NPD4171 | Clinical (unspecified phase) |
0.679 | Remote Similarity | NPD7988 | Suspended |
0.6786 | Remote Similarity | NPD798 | Discontinued |
0.6772 | Remote Similarity | NPD546 | Clinical (unspecified phase) |
0.6766 | Remote Similarity | NPD1412 | Clinical (unspecified phase) |
0.6736 | Remote Similarity | NPD248 | Discontinued |
0.6718 | Remote Similarity | NPD9291 | Approved |
0.6705 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.6687 | Remote Similarity | NPD1776 | Approved |
0.6687 | Remote Similarity | NPD1777 | Approved |
0.6667 | Remote Similarity | NPD1816 | Clinical (unspecified phase) |
0.6646 | Remote Similarity | NPD516 | Clinical (unspecified phase) |
0.6605 | Remote Similarity | NPD3083 | Approved |
0.6597 | Remote Similarity | NPD870 | Clinical (unspecified phase) |
0.659 | Remote Similarity | NPD5683 | Clinical (unspecified phase) |
0.659 | Remote Similarity | NPD6417 | Clinical (unspecified phase) |
0.659 | Remote Similarity | NPD5684 | Clinical (unspecified phase) |
0.659 | Remote Similarity | NPD5682 | Phase 3 |
0.6514 | Remote Similarity | NPD2630 | Approved |
0.6514 | Remote Similarity | NPD2631 | Clinical (unspecified phase) |
0.6514 | Remote Similarity | NPD2632 | Approved |
0.6493 | Remote Similarity | NPD9416 | Phase 3 |
0.6493 | Remote Similarity | NPD9417 | Phase 3 |
0.6477 | Remote Similarity | NPD4054 | Clinical (unspecified phase) |
0.6457 | Remote Similarity | NPD7138 | Phase 2 |
0.6357 | Remote Similarity | NPD1368 | Approved |
0.6242 | Remote Similarity | NPD282 | Approved |
0.6234 | Remote Similarity | NPD1118 | Discontinued |
0.6225 | Remote Similarity | NPD1119 | Phase 2 |
0.6188 | Remote Similarity | NPD3708 | Phase 2 |
0.6149 | Remote Similarity | NPD1354 | Approved |
0.6149 | Remote Similarity | NPD1355 | Clinical (unspecified phase) |
0.6149 | Remote Similarity | NPD1356 | Approved |
0.6142 | Remote Similarity | NPD6381 | Phase 2 |
0.6107 | Remote Similarity | NPD9633 | Phase 3 |
0.6101 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.6099 | Remote Similarity | NPD9406 | Approved |
0.609 | Remote Similarity | NPD2253 | Discontinued |
0.6085 | Remote Similarity | NPD2877 | Clinical (unspecified phase) |
0.6085 | Remote Similarity | NPD2876 | Phase 3 |
0.6076 | Remote Similarity | NPD7158 | Phase 1 |
0.6032 | Remote Similarity | NPD2965 | Clinical (unspecified phase) |
0.6022 | Remote Similarity | NPD5665 | Clinical (unspecified phase) |
0.6021 | Remote Similarity | NPD2824 | Phase 2 |
0.6014 | Remote Similarity | NPD9408 | Phase 3 |
0.6012 | Remote Similarity | NPD231 | Clinical (unspecified phase) |
0.6012 | Remote Similarity | NPD5768 | Phase 2 |
0.6 | Remote Similarity | NPD1061 | Clinical (unspecified phase) |
0.5966 | Remote Similarity | NPD1046 | Clinical (unspecified phase) |
0.595 | Remote Similarity | NPD6036 | Suspended |
0.5933 | Remote Similarity | NPD1127 | Approved |
0.5933 | Remote Similarity | NPD1128 | Approved |
0.5906 | Remote Similarity | NPD281 | Approved |
0.5868 | Remote Similarity | NPD3697 | Discontinued |
0.5868 | Remote Similarity | NPD2604 | Approved |
0.5854 | Remote Similarity | NPD9429 | Discontinued |
0.5849 | Remote Similarity | NPD1117 | Clinical (unspecified phase) |
0.5839 | Remote Similarity | NPD1730 | Discontinued |
0.58 | Remote Similarity | NPD4812 | Phase 1 |
0.5783 | Remote Similarity | NPD1731 | Clinical (unspecified phase) |
0.5778 | Remote Similarity | NPD223 | Clinical (unspecified phase) |
0.5769 | Remote Similarity | NPD535 | Approved |
0.5769 | Remote Similarity | NPD1063 | Phase 2 |
0.5752 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.5749 | Remote Similarity | NPD2180 | Approved |
0.5745 | Remote Similarity | NPD691 | Discontinued |
0.5742 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.5737 | Remote Similarity | NPD4599 | Clinical (unspecified phase) |
0.5736 | Remote Similarity | NPD2902 | Phase 2 |
0.5736 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.5733 | Remote Similarity | NPD9084 | Phase 2 |
0.5725 | Remote Similarity | NPD9585 | Discontinued |
0.5714 | Remote Similarity | NPD4495 | Phase 1 |
0.5692 | Remote Similarity | NPD9102 | Approved |
0.5692 | Remote Similarity | NPD9103 | Approved |
0.5659 | Remote Similarity | NPD9603 | Phase 3 |
0.5659 | Remote Similarity | NPD9604 | Approved |
0.5659 | Remote Similarity | NPD9602 | Phase 3 |
0.5646 | Remote Similarity | NPD578 | Discontinued |
0.5643 | Remote Similarity | NPD9415 | Clinical (unspecified phase) |
0.5625 | Remote Similarity | NPD3695 | Approved |
0.5625 | Remote Similarity | NPD3696 | Approved |
0.5607 | Remote Similarity | NPD527 | Clinical (unspecified phase) |
0.56 | Remote Similarity | NPD8830 | Phase 3 |
PubChem CID   | 65131 |
ChEMBL   | CHEMBL1688964 |
ZINC   |
Molecular Weight:   | 299.09 |
ALogP:   | -2.6755 |
MLogP:   | 1.35 |
XLogP:   | -2.111 |
# Rotatable Bonds:   | 7 |
Polar Surface Area:   | 176.44 |
# H-Bond Aceptor:   | 10 |
# H-Bond Donor:   | 7 |
# Rings:   | 3 |
# Heavy Atoms:   | 21 |